Etripamil

(Synonyms: MSP-2017; (-)-MSP-2017)
Customer Review

Based on 1 Customer Validation

Etripamil (MSP-2017) is a short-acting, L-type calcium-channel antagonist. Etripamil inhibits calcium influx through slow calcium channels, thereby slowing AV node conduction and prolonging the AV node refractory period. Etripamil increases heart rate and decreases systolic blood pressure. Etripamil can be used in the study of paroxysmal supraventricular tachycardia (PSVT).

For research use only. We do not sell to patients.

  • Purity: 98.10%
  • CAS No.: 1593673-23-4
  • Formula: C27H36N2O4
  • Molecular Weight:452.59
  • Storage:
    Pure form   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00